[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-169607-en":3,"doc-seo-169607-105":30,"detail-sidebar-cat-1-en-105":92},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":11,"category_id":12,"category_name":13,"doc_title":14,"doc_description":15,"doc_content":16,"file_id":17,"file_url":18,"file_type":19,"file_size":20,"view_count":4,"is_deleted":4,"is_public":11,"is_downloadable":11,"audit_status":11,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":15,"update_tm":28,"read_time":29},169607,1374402739827,"Nguyễn Văn Học","https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660",1,17,"Forms","Protocol v5 - Study Table of Contents","Protocol v5 outlines a comprehensive study plan for participant recruitment, eligibility screening, consent processes, and longitudinal follow-up. It specifies recruitment routes including critical care and other settings, defines clinical phenotypes of interest, and details laboratory sampling, sample handling, and hazardous specimen procedures. The protocol covers GenOMICC Acute sub-study rationale, laboratory schedules, outcome measures, statistical analysis, study management, and robust data management, access control, ethics, and future sample use.","\u000f\n\u0003Table of Contents\n\u0013TOC \\o \"1-3\" \\h \\z \\u\u0014\u0013 HYPERLINK \\l \"_Toc181256531\" \u0014Table of Contents\t\u0013 PAGEREF _Toc181256531 \\h \u00142\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256532\" \u0014Protocol authors and study staff\t\u0013 PAGEREF _Toc181256532 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256533\" \u0014Aims\t\u0013 PAGEREF _Toc181256533 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256534\" \u0014Objectives\t\u0013 PAGEREF _Toc181256534 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256535\" \u0014Recruitment from critical care\t\u0013 PAGEREF _Toc181256535 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256536\" \u0014Other recruitment\t\u0013 PAGEREF _Toc181256536 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256537\" \u0014Data management objectives\t\u0013 PAGEREF _Toc181256537 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256538\" \u0014Background\t\u0013 PAGEREF _Toc181256538 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256539\" \u0014Study design and implementation\t\u0013 PAGEREF _Toc181256539 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256540\" \u0014Clinical Conditions (Phenotypes) of interest\t\u0013 PAGEREF _Toc181256540 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256541\" \u0014Prospective recruitment\t\u0013 PAGEREF _Toc181256541 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256542\" \u0014Laboratory sampling\t\u0013 PAGEREF _Toc181256542 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256543\" \u0014GenOMICC Acute sub-study\t\u0013 PAGEREF _Toc181256543 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256544\" \u0014Rationale for GenOMICC Acute\t\u0013 PAGEREF _Toc181256544 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256545\" \u0014Eligibility criteria\t\u0013 PAGEREF _Toc181256545 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256546\" \u0014Recruitment procedures for GenOMICC Acute\t\u0013 PAGEREF _Toc181256546 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256547\" \u0014Recruitment of survivors\t\u0013 PAGEREF _Toc181256547 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256548\" \u0014Recruitment of a comparison (control) group\t\u0013 PAGEREF _Toc181256548 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256549\" \u0014Obtaining samples from participants in the community\t\u0013 PAGEREF _Toc181256549 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256550\" \u0014Repeat sampling of survivors\t\u0013 PAGEREF _Toc181256550 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256551\" \u0014Study eligibility\t\u0013 PAGEREF _Toc181256551 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256552\" \u0014Inclusion criteria\t\u0013 PAGEREF _Toc181256552 \\h \u001410\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256553\" \u0014Emerging Infections and exposures\t\u0013 PAGEREF _Toc181256553 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256554\" \u0014Exclusion criteria\t\u0013 PAGEREF _Toc181256554 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256555\" \u0014Additional groups\t\u0013 PAGEREF _Toc181256555 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256556\" \u0014Number of participants\t\u0013 PAGEREF _Toc181256556 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256557\" \u0014Modification of sampling and data collection during the study\t\u0013 PAGEREF _Toc181256557 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256558\" \u0014Standard of care for prospectively recruited patients\t\u0013 PAGEREF _Toc181256558 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256559\" \u0014Sampling and Data Collection procedures\t\u0013 PAGEREF _Toc181256559 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256560\" \u0014Sample and Data Collection Schedules\t\u0013 PAGEREF _Toc181256560 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256561\" \u0014Sample volumes\t\u0013 PAGEREF _Toc181256561 \\h \u001413\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256562\" \u0014Sampling procedure for patients or volunteers in the community\t\u0013 PAGEREF _Toc181256562 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256563\" \u0014Sample handling\t\u0013 PAGEREF _Toc181256563 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256564\" \u0014Potentially hazardous samples\t\u0013 PAGEREF _Toc181256564 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256565\" \u0014Follow up\t\u0013 PAGEREF _Toc181256565 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256566\" \u0014Outcome measures\t\u0013 PAGEREF _Toc181256566 \\h \u001415\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256567\" \u0014Enrolment procedures\t\u0013 PAGEREF _Toc181256567 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256568\" \u0014Enrolment procedures for prospectively recruited patients\t\u0013 PAGEREF _Toc181256568 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256569\" \u0014Procedures for consenting patients with regained capacity\t\u0013 PAGEREF _Toc181256569 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256570\" \u0014Attempts to re-consent following discharge\t\u0013 PAGEREF _Toc181256570 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256571\" \u0014Capacity assessments\t\u0013 PAGEREF _Toc181256571 \\h \u001418\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc181256572\" \u0014Procedures for initial approach to consent and sample elig","cbCainWdvXf2EKr4","https://ap.wps.com/l/cbCainWdvXf2EKr4","docx",291568,31,"English","en",105,"# Protocol authors and study staff\n## Aims\n## Objectives\n## Recruitment from critical care\n## Other recruitment\n## Data management objectives\n## Background\n## Study design and implementation\n## Clinical Conditions (Phenotypes) of interest\n## Prospective recruitment\n## Laboratory sampling\n## GenOMICC Acute sub-study\n## Rationale for GenOMICC Acute\n## Eligibility criteria\n## Recruitment procedures for GenOMICC Acute\n## Recruitment of survivors\n## Recruitment of a comparison (control) group\n## Obtaining samples from participants in the community\n## Repeat sampling of survivors\n## Study eligibility\n## Inclusion criteria\n## Emerging Infections and exposures\n## Exclusion criteria\n## Additional groups\n## Number of participants\n## Modification of sampling and data collection during the study","[{\"question\":\"What recruitment pathways does the protocol describe?\",\"answer\":\"It details recruitment from critical care and other recruitment routes, including prospective recruitment and approaches to enrolling survivors and comparison (control) participants.\"},{\"question\":\"How does the protocol handle laboratory sampling and specimen safety?\",\"answer\":\"It specifies laboratory sampling workflows, sample handling procedures, hazardous sample precautions, sampling and data collection schedules, and sample volumes.\"},{\"question\":\"What elements does the protocol include for ethics and informed consent?\",\"answer\":\"It covers ethical considerations and informed consent, including procedures for consenting participants with regained capacity, parents of cases, and patients after death.\"}]","Protocol v5 - Study Table of Contents | DOCX",1788258234,11,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":14,"keywords":34,"description":15,"schema_data":35,"social_meta":87,"head_meta":89,"extra_data":91,"updated_unix":28},"protocol-v5-study-table-of-contents","",{"@graph":36,"@context":86},[37,54,69],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,51],{"item":41,"name":42,"@type":43,"position":11},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/template/","Template",2,{"item":49,"name":13,"@type":43,"position":50},"https://docshare.wps.com/template/forms/",3,{"item":52,"name":14,"@type":43,"position":53},"https://docshare.wps.com/template/protocol-v5-study-table-of-contents/169607/",4,{"url":52,"name":14,"@type":55,"author":56,"headline":14,"publisher":58,"fileFormat":61,"inLanguage":23,"description":15,"dateModified":62,"datePublished":63,"encodingFormat":61,"isAccessibleForFree":64,"interactionStatistic":65},"DigitalDocument",{"name":9,"@type":57},"Person",{"url":41,"name":59,"@type":60},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-03","2026-09-01",true,{"@type":66,"interactionType":67,"userInteractionCount":47},"InteractionCounter",{"@type":68},"ViewAction",{"@type":70,"mainEntity":71},"FAQPage",[72,78,82],{"name":73,"@type":74,"acceptedAnswer":75},"What recruitment pathways does the protocol describe?","Question",{"text":76,"@type":77},"It details recruitment from critical care and other recruitment routes, including prospective recruitment and approaches to enrolling survivors and comparison (control) participants.","Answer",{"name":79,"@type":74,"acceptedAnswer":80},"How does the protocol handle laboratory sampling and specimen safety?",{"text":81,"@type":77},"It specifies laboratory sampling workflows, sample handling procedures, hazardous sample precautions, sampling and data collection schedules, and sample volumes.",{"name":83,"@type":74,"acceptedAnswer":84},"What elements does the protocol include for ethics and informed consent?",{"text":85,"@type":77},"It covers ethical considerations and informed consent, including procedures for consenting participants with regained capacity, parents of cases, and patients after death.","https://schema.org",{"og:url":52,"og:type":88,"og:title":14,"og:site_name":59,"og:description":15},"article",{"robots":90,"canonical":52},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":93},[94,98,103,108,113,118,121,126,131],{"id":29,"doc_module":11,"doc_module_name":46,"category_name":95,"show_sort_weight":96,"slug":97},"Presentations",90,"presentations",{"id":99,"doc_module":11,"doc_module_name":46,"category_name":100,"show_sort_weight":101,"slug":102},12,"Resumes",80,"resumes",{"id":104,"doc_module":11,"doc_module_name":46,"category_name":105,"show_sort_weight":106,"slug":107},14,"Invoices",70,"invoices",{"id":109,"doc_module":11,"doc_module_name":46,"category_name":110,"show_sort_weight":111,"slug":112},15,"Posters",60,"posters",{"id":114,"doc_module":11,"doc_module_name":46,"category_name":115,"show_sort_weight":116,"slug":117},16,"Social Media",50,"social-media",{"id":12,"doc_module":11,"doc_module_name":46,"category_name":13,"show_sort_weight":119,"slug":120},40,"forms",{"id":122,"doc_module":11,"doc_module_name":46,"category_name":123,"show_sort_weight":124,"slug":125},18,"Letters",30,"letters",{"id":127,"doc_module":11,"doc_module_name":46,"category_name":128,"show_sort_weight":129,"slug":130},21,"Paper Templates",5,"papers-templates",{"id":132,"doc_module":11,"doc_module_name":46,"category_name":133,"show_sort_weight":4,"slug":134},158,"General","general-158"]